Base case results for dapagliflozin arm versus acarbose arm.
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接：
官方服务：
资源简介：
Base case results for dapagliflozin arm versus acarbose arm.
应用场景：
创建时间：
2016-11-03
相关数据集
Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis
IntroductionWhen first line therapy with metformin is insufficient for patients with type 2 diabetes (T2D), the optimal adjunctive therapy is unclear. We assessed the efficacy and safety of adjunctive
Figshare2016-01-15 更新50
Dataset from Effect of Semaglutide Once-weekly Versus Insulin Aspart Three Times Daily, Both as Add on to Metformin and Optimised Insulin Glargine (U100) in Subjects With Type 2 Diabetes A 52-week, Multi-centre, Multinational, Open-label, Active-controlled, Two Armed, Parallel-group, Randomised Trial in Subjects With Type 2 Diabetes
This study will compare the effect of semaglutide once weekly to insulin aspart 3 times daily as add on to metformin and insulin glargine in people with type 2 diabetes. Participants will either get i
NIAID Data Ecosystem30
Table_1_The association between different hypoglycemic regimens and postoperative diabetic macular edema after vitrectomy in the Japanese patients with proliferative diabetic retinopathy.xlsx
PurposeTo study the association between different hypoglycemic regimens and postoperative diabetic macular edema (DME). MethodsA secondary analysis based on a retrospective cohort study. ResultsIn thi
NIAID Data Ecosystem20
Results of meta-regression analysis for the relationship between DPP-4is plus metformin versus SUs plus metformin on the risk of MACE.
Results of meta-regression analysis for the relationship between DPP-4is plus metformin versus SUs plus metformin on the risk of MACE.
Figshare2025-05-05 更新40
Hazard ratios for the association between DPP-4 inhibitor use and primary composite outcome, acute myocardial infraction, stroke, and heart failure compared to Sulfonylureas and metformin.
Hazard ratios for the association between DPP-4 inhibitor use and primary composite outcome, acute myocardial infraction, stroke, and heart failure compared to Sulfonylureas and metformin.
NIAID Data Ecosystem20
